Palbociclib CAS 571190-30-2 Tsarkake>99.5% (HPLC) API ɗin Featurer Hoton Factory

Palbociclib CAS 571190-30-2 Tsarkake>99.5% (HPLC) Kamfanin API

Takaitaccen Bayani:

Sunan Sinadari: Palbociclib

Saukewa: 571190-30-2

Tsafta:> 99.5% (HPLC)

Bayyanar: Fari ko Kashe-Farin Foda

API A cikin Maganin Ciwon Kansa

Kyakkyawan inganci, Samar da Kasuwanci

E-Mail: alvin@ruifuchem.com

Aika mana imel

Cikakken Bayani

Samfura masu dangantaka

Tags samfurin

Bayani:

Ruifu Chemical Supply Palbociclib Matsakaici masu dangantaka:
Palbociclib CAS 571190-30-2
5-Bromo-2,4-Dichloropyrimidine CAS 36082-50-5
5-Bromo-2-Chloro-N-Cyclopentylpyrimidin-4-Amine CAS 733039-20-8
tert-Butyl 4-(6-Nitropyridin-3-yl) piperazine-1-Carboxylate CAS 571189-16-7
tert-Butyl 4-(6-Amino-3-Pyridyl)piperazine-1-Carboxylate CAS 571188-59-5
6-Bromo-2-Chloro-8-Cyclopentyl-5-Methylpyrido-[2,3-d]pyrimidin-7(8H) -daya CAS 1016636-76-2
2-Chloro-8-Cyclopentyl-5-Methyl-8H-Pyrido[2,3-d] pyrimidin-7-daya CAS 1013916-37-4

Abubuwan Sinadarai:

Sunan Sinadari	Palbociclib
Makamantu	PD-0332991;Otava-Bb 1115529;Ibrance
Lambar CAS	571190-30-2
Matsayin Hannun jari	A cikin Hannun jari, Ma'aunin samarwa Har zuwa Ton
Tsarin kwayoyin halitta	Saukewa: C24H29N7O2
Nauyin Kwayoyin Halitta	447.54
Alamar	Ruifu Chemical

Ƙayyadaddun bayanai:

Abu	Ƙayyadaddun bayanai
Bayyanar	Fari ko Kashe-Farin Foda
1H NMR Spectrum	Daidaita Da Tsarin
HPLC	Daidaita Da Tsarin
Abubuwa masu alaƙa
Rashin Tsabtace Mutum	<0.50%
Jimlar ƙazanta	<1.00%
Asara akan bushewa	<0.50%
Ragowa akan Ignition	<0.10%
Karfe masu nauyi	<10ppm
Tsarkake / Hanyar Bincike	> 99.5% (HPLC)
Matsayin Gwaji	Matsayin Kasuwanci
Amfani	API, A cikin Maganin Ciwon Kansa

Kunshin & Ajiya:

Kunshin: Bottle, Aluminum tsare jakar, 25kg / kwali Drum, ko bisa ga abokin ciniki ta bukata

Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske da danshi

Amfani:

FAQ:

Aikace-aikace:

Palbociclib (CAS: 571190-30-2) shine mai hanawa kinase mai dogaro da cyclin (CDK) ta baka tare da yuwuwar aikin antineoplastic.Palbociclib ya zaɓi ya hana cyclin-dependent kinase 4 (CDK4) da 6 (CDK6), ta haka yana hana retinoblastoma (Rb) furotin phosphorylation a farkon lokacin G1 wanda ke haifar da kama sake zagayowar tantanin halitta.Wannan yana hana kwafin DNA kuma yana rage haɓakar ƙwayoyin ƙari.Palbociclib shine wakilin farko na sabon rukunin magunguna na masu hana kinase masu dogaro da cyclin.Wannan tasirin yana iyakance yaduwar tantanin halitta (ci gaban sel da rarrabuwa).Ana amfani da shi azaman wakili na antineoplastic a cikin ci gaba ko ciwon daji na nono.